The Drug Controller General of India (DCGI) certified 2-deoxy-d-glucose (2-DG) for emergency use in persons with moderate and severe COVID-19 on May 1 to support disease prevention. Researchers from the Institute of Nuclear Medicine and Allied Sciences, part of the Defence Research and Development Organisation (DRDO), and Dr Reddy’s Laboratories collaborated on this medicine. The DCGI approved 2-DG based on insufficient data, similar to the approvals of favipiravir, itolizumab, and Verafin. 2-DG is a modified glucose molecule that has discovered … Continue reading “DRDO’S DRUG FOR COVID-19”
DRDO’S DRUG FOR COVID-19
Author covidWarrior Posted on June 1, 2021June 1, 2021Categories Covid-19 Leave a comment on DRDO’S DRUG FOR COVID-19